Publication: An MPER antibody neutralizes HIV-1 using germline features shared among donors
dc.contributor.author | Lei Zhang | en_US |
dc.contributor.author | Adriana Irimia | en_US |
dc.contributor.author | Lingling He | en_US |
dc.contributor.author | Elise Landais | en_US |
dc.contributor.author | Kimmo Rantalainen | en_US |
dc.contributor.author | Daniel P. Leaman | en_US |
dc.contributor.author | Thomas Vollbrecht | en_US |
dc.contributor.author | Armando Stano | en_US |
dc.contributor.author | Daniel I. Sands | en_US |
dc.contributor.author | Arthur S. Kim | en_US |
dc.contributor.author | George Miiro | en_US |
dc.contributor.author | Jennifer Serwanga | en_US |
dc.contributor.author | Anton Pozniak | en_US |
dc.contributor.author | Dale McPhee | en_US |
dc.contributor.author | Oliver Manigart | en_US |
dc.contributor.author | Lawrence Mwananyanda | en_US |
dc.contributor.author | Etienne Karita | en_US |
dc.contributor.author | André Inwoley | en_US |
dc.contributor.author | Walter Jaoko | en_US |
dc.contributor.author | Jack DeHovitz | en_US |
dc.contributor.author | Linda Gail Bekker | en_US |
dc.contributor.author | Punnee Pitisuttithum | en_US |
dc.contributor.author | Robert Paris | en_US |
dc.contributor.author | Susan Allen | en_US |
dc.contributor.author | Pascal Poignard | en_US |
dc.contributor.author | Dennis R. Burton | en_US |
dc.contributor.author | Ben Murrell | en_US |
dc.contributor.author | Andrew B. Ward | en_US |
dc.contributor.author | Jiang Zhu | en_US |
dc.contributor.author | Ian A. Wilson | en_US |
dc.contributor.author | Michael B. Zwick | en_US |
dc.contributor.other | Universite Grenoble Alpes | en_US |
dc.contributor.other | International AIDS Vaccine Initiative | en_US |
dc.contributor.other | Centre Hospitalier Universitaire de Treichville | en_US |
dc.contributor.other | Uganda Virus Research Institute | en_US |
dc.contributor.other | University of Nairobi | en_US |
dc.contributor.other | University of California, San Diego | en_US |
dc.contributor.other | NHS Foundation Trust | en_US |
dc.contributor.other | SUNY Downstate Medical Center | en_US |
dc.contributor.other | Washington University School of Medicine in St. Louis | en_US |
dc.contributor.other | Massachusetts Institute of Technology | en_US |
dc.contributor.other | Karolinska University Hospital | en_US |
dc.contributor.other | Armed Forces Research Institute of Medical Sciences, Thailand | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Scripps Research Institute | en_US |
dc.contributor.other | Emory University | en_US |
dc.contributor.other | University of Cape Town | en_US |
dc.contributor.other | CTK Biotech, Inc. | en_US |
dc.contributor.other | NRL | en_US |
dc.date.accessioned | 2020-01-27T07:35:37Z | |
dc.date.available | 2020-01-27T07:35:37Z | |
dc.date.issued | 2019-12-01 | en_US |
dc.description.abstract | © 2019, The Author(s). The membrane-proximal external region (MPER) of HIV-1 envelope glycoprotein (Env) can be targeted by neutralizing antibodies of exceptional breadth. MPER antibodies usually have long, hydrophobic CDRH3s, lack activity as inferred germline precursors, are often from the minor IgG3 subclass, and some are polyreactive, such as 4E10. Here we describe an MPER broadly neutralizing antibody from the major IgG1 subclass, PGZL1, which shares germline V/D-region genes with 4E10, has a shorter CDRH3, and is less polyreactive. A recombinant sublineage variant pan-neutralizes a 130-isolate panel at 1.4 μg/ml (IC50). Notably, a germline revertant with mature CDR3s neutralizes 12% of viruses and still binds MPER after DJ reversion. Crystal structures of lipid-bound PGZL1 variants and cryo-EM reconstruction of an Env-PGZL1 complex reveal how these antibodies recognize MPER and viral membrane. Discovery of common genetic and structural elements among MPER antibodies from different patients suggests that such antibodies could be elicited using carefully designed immunogens. | en_US |
dc.identifier.citation | Nature Communications. Vol.10, No.1 (2019) | en_US |
dc.identifier.doi | 10.1038/s41467-019-12973-1 | en_US |
dc.identifier.issn | 20411723 | en_US |
dc.identifier.other | 2-s2.0-85075605452 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/50026 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075605452&origin=inward | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Chemistry | en_US |
dc.title | An MPER antibody neutralizes HIV-1 using germline features shared among donors | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075605452&origin=inward | en_US |